GMAB Genmab A/S logo

GMAB Genmab A/S

Healthcare
$26.87-0.67%ClosedMarket Cap: $16.50B

As of 2026-05-25

Institutional Ownership Summary

Investors Holding

294

13F Shares

73,220,359

Ownership %

11.9%

New Positions

74

Increased Positions

200

Closed Positions

37

Reduced Positions

52

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
CNCRLoncar Cancer Immunotherapy ETF35,7933.42%
CANCTema Oncology ETF182,9242.95%
AADRAdvisorShares Dorsey Wright30,8531.85%
IBBiShares Biotechnology ETF3,555,0981.18%
AVDEX28,6510.17%
AVDEAvantis International Equity ETF463,8460.09%
FENIFidelity Enhanced International ETF155,8910.05%
AVIVAvantis International Large Cap Value ETF17,4830.04%
ONEQFidelity Nasdaq Composite Index ETF25,5590.01%
DFAIDimensional - International Core Equity Market ETF22,6200.00%
FBTFirst Trust NYSE Arca Biotechnology Index Fund2,385,2670.00%
FTQIFirst Trust Nasdaq BuyWrite Income ETF70,2560.00%